1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania Health Systems, Philadelphia, PA
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore MD
3The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD
Reprint requests to: Kimberly Levinson, MD, MPH, Phipps 274, 600 N Wolfe St, Baltimore, MD. E-mail: [email protected]
A.F.R. has consulted for and received funding from Hologic. The other authors have declared they have no conflicts of interest.
This study was partially supported by grants from the Johns Hopkins Department of Gynecology and Obstetrics' Kelly Society (to A.J.B.S.) and Johns Hopkins Medicine's Cervical Cancer SPORE (to A.F.R.).
A.J.B.S. and K.L. participated in study conception and design and analysis and interpretation of data. A.F.R. and A.L.B. participated in interpretation of the data and critical revision of the manuscript.
A previous version of this article was presented at the 2019 Society for Gynecologic Oncology Meeting, Honolulu, Hawaii, March 17, 2019.
This work was reviewed and found to be exempt by the Johns Hopkins School of Medicine Institutional Review Board.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.jlgtd.com).